buyModerate
Antony A Riley bought $255k of FBRX
CHIEF FINANCIAL OFFICER at Forte Biosciences, Inc.. 9,680 shares at an average of $26.33, traded Dec 30, 2025, filed Jan 2, 2026.
Conviction score
41Value
$255k
9,680 shares
Holdings after
41,520
+30% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +22RoleCFO
- +13Trade size$255k at market
- +6Relative to holdingsHoldings up 30%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001339375-26-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 30, 2025 | POpen-market purchase Common Stock | +9,680 | $26.33 | $255k | 41,520 | Jan 2, 2026 |
| Jan 1, 2026 | MOption exercise Common Stock | +375 | $0.00 | $0 | 41,895 | Jan 2, 2026 |
| Jan 1, 2026 | FTax withholding Common Stock | -154 | $27.27 | $4,200 | 41,741 | Jan 2, 2026 |
| Jan 1, 2026 | MOption exercise Restricted Stock Unitsderivative | -375 | $0.00 | $0 | 1,500 | Jan 2, 2026 |
Related signals
Other insiders at Forte Biosciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 42Moderate | FBRXbuy Forte Biosciences, Inc. | Antony A Riley CHIEF FINANCIAL OFFICER | $125k 22,514 shares | +273% | |
| 15Weak | FBRXbuy Forte Biosciences, Inc. | Paul A. Wagner See Remarks | $7,525 10,000 shares | +1% | |
| 20Weak | FBRXbuy Forte Biosciences, Inc. | Paul A. Wagner See Remarks | $15k 20,520 shares | +1% | |
| 20Weak | FBRXbuy Forte Biosciences, Inc. | Paul A. Wagner See Remarks | $19k 29,776 shares | +2% | |
| 25Weak | FBRXbuy Forte Biosciences, Inc. | Paul A. Wagner See Remarks | $30k 51,203 shares | +3% | |
| 10Weak | FBRXbuy Forte Biosciences, Inc. | Paul A. Wagner See Remarks | $3,220 7,366 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.